2074 studies found for:    diabetes | NIH
Show Display Options
RSS Create an RSS feed from your search for:
diabetes | NIH
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting Look AHEAD: Action for Health in Diabetes
Conditions: Diabetes;   Myocardial Infarction;   Stroke;   Kidney Diseases;   Bone Diseases;   Dyslipidemia
Interventions: Behavioral: Lifestyle Intervention;   Behavioral: Diabetes Support and Education
2 Recruiting Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
Conditions: Autoantibody Positive;   Non-diabetic Relatives at Risk for Type 1 Diabetes;   High Risk;   Impaired Glucose Tolerance
Intervention: Drug: Teplizumab
3 Unknown  Diabetes Prevention Program Outcomes Study
Condition: Diabetes Mellitus
Interventions: Behavioral: Group Lifestyle;   Drug: Metformin;   Behavioral: Boost Lifestyle
4 Recruiting Pathway to Prevention Study
Condition: Diabetes Mellitus, Type 1
Intervention:
5 Active, not recruiting ATG-GCSF in New Onset Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Anti-Thymocyte Globulin (ATG);   Drug: Granulocyte colony stimulating factor (GCSF);   Drug: Placebo (for ATG);   Drug: Placebo (for GCSF)
6 Active, not recruiting Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Oral Insulin
7 Completed Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Condition: Diabetes Mellitus, Type 1
Interventions: Procedure: Mixed Meal Tolerance Test;   Procedure: Glucagon Stimulation Test
8 Completed
Has Results
Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: CTLA-4 Ig;   Other: Placebo
9 Completed
Has Results
New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Mycophenolate mofeteil (MMF);   Drug: Daclizumab (DZB);   Drug: Placebo control for Mycophenolate mofeteil (MMF);   Drug: Placebo control for Daclizumab (DZB)
10 Completed
Has Results
Effects of Rituximab on the Progression of Type 1 Diabetes in New Onset Subjects
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: Anti-CD20 (rituximab)
11 Recruiting CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Conditions: Abnormal Glucose Tolerance;   Type 1 Diabetes
Interventions: Drug: CTLA4-Ig (Abatacept);   Drug: Placebo
12 Completed Effects of Recombinant Human Glutamic Acid Decarboxylase . . .
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: GAD-Alum;   Drug: Aluminum hydroxide
13 Completed Continuous Glucose Monitors for Children With Diabetes Mellitus
Condition: Diabetes Mellitus, Insulin-Dependent
Interventions: Device: The GlucoWatch® G2™ Biographer (GW2B);   Device: The Continuous Glucose Monitoring System (CGMS™)
14 Completed The Diabetes Prevention Trial of Type 1 Diabetes (DPT-1)
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Crystallized human recombinant insulin
15 Completed Randomized Clinical Trial to Assess the Effectiveness of the GlucoWatch Biographer
Condition: Diabetes Mellitus, Insulin-Dependent
Interventions: Device: GlucoWatch® G2™ Biographer (GW2B);   Device: Continuous Glucose Monitoring System (CGMS)
16 Active, not recruiting TEDDY - The Environmental Determinants of Diabetes in the Young
Condition: Type 1 Diabetes Mellitus
Intervention:
17 Completed Pilot Study of the GlucoWatch G2 Biographer for the Management of Type 1 Diabetes in Children
Condition: Diabetes Mellitus, Insulin-Dependent
Interventions: Device: GlucoWatch® G2™ Biographer (GW2B);   Device: Continuous Glucose Monitoring System™ (CGMS)
18 Terminated
Has Results
Inducing Remission in Type 1 Diabetes With Alefacept
Condition: New-onset Type 1 Diabetes Mellitus
Interventions: Biological: Alefacept;   Drug: Placebo
19 Completed The Effect of Insulin During Exercise on the Development of Low Blood Sugar in Individuals With Type I Diabetes
Condition: Diabetes Mellitus, Type I
Intervention:
20 Enrolling by invitation TODAY2 Phase 2 Follow-up
Condition: Type 2 Diabetes
Intervention: Other: TODAY cohort

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years